Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Lymphatic Diseases or Hematopoietic Malignancy
and you are
-
The phase for this study is not defined.
Show me locations

The purpose

For the next 5‐10 years or possibly longer, a high proportion of the Cord Blood Banks (CBB) inventory worldwide will be composed of unlicensed umbilical cord blood (UCB) units. While Food and Drug Administration (FDA)‐licensed units will be prioritized, it will always be possible that an unlicensed unit will have known attributes, making it a better source of cells for the given indication. Because of the wide variety of current and potential indications as a source of cells for hematopoietic reconstitution or other form of cellular therapy, it is critical that the investigators have access to unlicensed UCB units.

Provided treatments

  • Biological: Umbilical Cord Blood (UCB)
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01451502. The sponsor of the trial is Masonic Cancer Center, University of Minnesota and it is looking for 250 volunteers for the current phase.
Official trial title:
Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units